Effect of Intravenous Hyoscine Butylbromide Injection on Labour in High Risk Women
Study the Effect of Intravenous Hyoscine Butylbromide Injection on the Duration and Progress of First Stage Labour in High Risk Women
Sponsor: Cairo University
A PHASE4 clinical study on Vaginal Delivery, this trial is completed. The trial is conducted by Cairo University and has accumulated 9 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Apr 2022 — Jul 2024 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Oct 2021 — Apr 2022 [monthly]
Recruiting PHASE4
Status: Unknown Status → Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Unknown Status PHASE4
▶ Show 4 earlier versions
-
May 2019 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jun 2018 — May 2019 [monthly]
Recruiting PHASE4
-
May 2017 — Jun 2018 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Feb 2017 — May 2017 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Cairo University
For direct contact, visit the study record on ClinicalTrials.gov .